Table 1.
Baseline characteristics of collected clinical samples from the two groups of patients.
| Categories | Total | CAS | Non-CAS | p-Value |
|---|---|---|---|---|
| (n = 74) | (n = 25) | (n = 49) | ||
| Men, n (%) | 58 (78.4%) | 16 (64.0%) | 42 (85.7%) | 0.032 |
| Age (year) | 65 (55–73) | 63 (53–69) | 68 (56–76) | 0.076 |
| Smoking, n (%) | 18 (24.3%) | 6 (24.0%) | 12 (24.5%) | 0.963 |
| Drinking, n (%) | 8 (10.8%) | 1 (4.0%) | 7 (14.3%) | 0.253 |
| Hypertension, n (%) | 54 (73.0%) | 17 (68.0%) | 37 (75.5%) | 0.401 |
| DM, n (%) | 27 (36.5%) | 8 (32.0%) | 19 (38.8%) | 0.524 |
| Fast blood glucose (mmol/L) | 5.5 (4.8–7.0) | 5.3 (4.7–5.6) | 6.0 (4.9–8.5) | 0.005 |
| HbA1c (%) | 5.8 (5.5–7.2) | 5.7 (5.5–6.3) | 5.9 (5.4–7.8) | 0.072 |
| Total cholesterol (mmol/L) | 3.8 (3.0–4.5) | 3.6 (3.0–4.2) | 3.9 (3.0–4.7) | 0.139 |
| Total triglyceride (mmol/L) | 1.2 (0.9–2.1) | 1.1 (0.8–1.3) | 1.7 (0.9–2.3) | 0.116 |
| LDLC (mmol/L) | 2.0 (±0.7) | 1.9 (±0.7) | 2.0 (±0.8) | 0.348 |
| HDLC (mmol/L) | 1.2 (±0.6) | 1.2 (±0.5) | 1.2 (±0.7) | 0.665 |
| hsCRP (mg/L) | 2.45 (0.50–35.80) | 0.400 (0.150–1.95) | 7.20 (1.35–63.50) | <0.001 |
| cTnT (ng/mL) | 0.048 (0.009–0.209) | 0.009 (0.007–0.015) | 0.081 (0.033–0.427) | 0.007 |
| CK-MB (U/L) | 16.0 (12.8–22.0) | 14.0 (12.0–17.0) | 18.0 (14.0–24.0) | 0.007 |
| CK-MM (U/L) | 66.0 (41.8–116.3) | 76.0 (50.0–113.5) | 57.0 (27.5–149.8) | 0.386 |
| log10(proBNP) (pg/mL) | 2.7 (2.1–3.2) | 2.3 (1.8–2.7) | 2.8 (2.3–3.3) | 0.013 |
| LVEF (%) | 62 (52–66) | 62 (56–67) | 62 (50–66) | 0.543 |
| Hemoglobin (g/L) | 128 (113–140) | 127 (121–137) | 129.0 (106–141) | 0.504 |
| Albumin (g/L) | 40 (35–43) | 41 (39–44) | 38 (33–42) | 0.025 |
| Blood creatinine (µmol/L) | 84 (70–113) | 83 (58–104) | 85 (72–136) | 0.448 |
| SELENBP1 (ng/L) | 209.8 (161.0–272.2) | 151.1 (143.9–163.6) | 234.4 (208.5–302.9) | <0.001 |
| VCL (ng/mL) | 113.1 (90.3–136.0) | 86.7 (77.8–96.6) | 126.0 (110.5–165.7) | <0.001 |
| β-blocker, n (%) | 30 (40.5%) | 10 (40.0%) | 20 (40.8%) | 0.946 |
| CCB, n (%) | 30 (40.5%) | 9 (36.0%) | 21 (42.9%) | 0.570 |
| eGFR (mL/min/1.73 m2) | 80 (54–96) | 80 (60–96) | 79 (52–96) | 0.357 |
| urine acid, µmol/L | 352.0 (291.5–411.0) | 341.0 (291.5–406.0) | 356.0 (291.0–417.0) | 0.727 |
Data are expressed as mean ± SD, number (percentage), or median (interquartile range). CCB—calcium channel blocker; CK-MB—creatine kinase-MB; CK-MM—creatine kinase-MM; cTnT—cardiac troponins T; DM—diabetes mellitus; eGFR—estimated glomerular filtration rate; HbA1c—hemoglobin A1c; HDLC—high-density lipoprotein cholesterol; hsCRP—high-sensitivity C-reactive protein; LDLC—low-density lipoprotein cholesterol; LVEF—left ventricular ejection fraction; proBNP—pro-brain natriuretic peptide.